Kinepolis Group NV (LON:0QV7)
30.55
-0.20 (-0.65%)
At close: Oct 16, 2025
Kinepolis Group NV Market Cap
Kinepolis Group NV has a market cap or net worth of 720.89 million as of October 17, 2025. Its market cap has decreased by -19.75% in one year.
Market Cap
720.89M
Enterprise Value
1.28B
Revenue
508.57M
Ranking
n/a
PE Ratio
17.77
Stock Price
30.55
Market Cap Chart
Since November 10, 1999, Kinepolis Group NV's market cap has increased from 343.69M to 720.89M, an increase of 109.75%. That is a compound annual growth rate of 2.90%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 17, 2025 | 720.89M | -17.22% |
Dec 31, 2024 | 870.87M | -16.44% |
Dec 29, 2023 | 1.04B | 12.35% |
Dec 30, 2022 | 927.62M | -25.03% |
Dec 31, 2021 | 1.24B | 47.89% |
Dec 31, 2020 | 836.67M | -37.93% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 194.68B |
HSBC Holdings | 170.04B |
Shell | 155.14B |
Unilever | 114.27B |
Rolls-Royce Holdings | 95.96B |
Rio Tinto Group | 87.63B |
British American Tobacco p.l.c. | 83.30B |
GSK plc | 65.72B |